1
项与 依那西普生物类似药(Zenotech Laboratories Ltd.) 相关的临床试验A Multicenter, Randomized, Placebo and Active Comparator-controlled Clinical Trial to Study the Efficacy, Safety and Pharmacokinetics (PK) of Tildrakizumab in Pediatric Subjects From 6 to <18 Years of Age With Moderate to Severe Chronic Plaque Psoriasis
The study has been designed with three components. Part A is an open label PK study followed by a randomized trial component (Part B) followed by open label Long Term Extension (LTE).
The initial PK analysis is first done in adolescent subjects (12 to <18 years) before initiating the PK study in younger cohort (6 to <12 years)
100 项与 依那西普生物类似药(Zenotech Laboratories Ltd.) 相关的临床结果
100 项与 依那西普生物类似药(Zenotech Laboratories Ltd.) 相关的转化医学
100 项与 依那西普生物类似药(Zenotech Laboratories Ltd.) 相关的专利(医药)
100 项与 依那西普生物类似药(Zenotech Laboratories Ltd.) 相关的药物交易